Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA CIPLA AUROBINDO PHARMA/
CIPLA
 
P/E (TTM) x 12.6 33.8 37.3% View Chart
P/BV x 1.1 4.3 25.5% View Chart
Dividend Yield % 2.0 0.5 434.3%  

Financials

 AUROBINDO PHARMA   CIPLA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-22
CIPLA
Mar-22
AUROBINDO PHARMA/
CIPLA
5-Yr Chart
Click to enlarge
High Rs1,0641,083 98.2%   
Low Rs584806 72.5%   
Sales per share (Unadj.) Rs400.3269.7 148.4%  
Earnings per share (Unadj.) Rs45.731.7 144.1%  
Cash flow per share (Unadj.) Rs64.944.8 145.1%  
Dividends per share (Unadj.) Rs9.005.00 180.0%  
Avg Dividend yield %1.10.5 206.4%  
Book value per share (Unadj.) Rs419.4257.8 162.7%  
Shares outstanding (eoy) m585.94806.81 72.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.13.5 58.8%   
Avg P/E ratio x18.029.8 60.5%  
P/CF ratio (eoy) x12.721.1 60.1%  
Price / Book Value ratio x2.03.7 53.6%  
Dividend payout %19.715.8 124.9%   
Avg Mkt Cap Rs m482,799762,177 63.3%   
No. of employees `000NANA-   
Total wages/salary Rs m34,50935,299 97.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m234,555217,633 107.8%  
Other income Rs m3,2263,217 100.3%   
Total revenues Rs m237,781220,851 107.7%   
Gross profit Rs m42,56643,298 98.3%  
Depreciation Rs m11,26510,520 107.1%   
Interest Rs m4861,064 45.7%   
Profit before tax Rs m34,04034,933 97.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2569,338 77.7%   
Profit after tax Rs m26,78425,595 104.6%  
Gross profit margin %18.119.9 91.2%  
Effective tax rate %21.326.7 79.7%   
Net profit margin %11.411.8 97.1%  
BALANCE SHEET DATA
Current assets Rs m181,227147,108 123.2%   
Current liabilities Rs m81,56049,129 166.0%   
Net working cap to sales %42.545.0 94.4%  
Current ratio x2.23.0 74.2%  
Inventory Days Days2563 39.9%  
Debtors Days Days626 1,087.1%  
Net fixed assets Rs m155,104119,415 129.9%   
Share capital Rs m5861,614 36.3%   
"Free" reserves Rs m245,174206,364 118.8%   
Net worth Rs m245,760207,977 118.2%   
Long term debt Rs m2,4924,162 59.9%   
Total assets Rs m336,331266,523 126.2%  
Interest coverage x71.033.8 209.7%   
Debt to equity ratio x00 50.7%  
Sales to assets ratio x0.70.8 85.4%   
Return on assets %8.110.0 81.1%  
Return on equity %10.912.3 88.6%  
Return on capital %13.917.0 82.0%  
Exports to sales %31.126.2 118.4%   
Imports to sales %11.98.2 145.7%   
Exports (fob) Rs m72,86257,094 127.6%   
Imports (cif) Rs m27,96517,803 157.1%   
Fx inflow Rs m77,24560,180 128.4%   
Fx outflow Rs m31,52417,803 177.1%   
Net fx Rs m45,72142,376 107.9%   
CASH FLOW
From Operations Rs m50,16533,259 150.8%  
From Investments Rs m-32,116-18,719 171.6%  
From Financial Activity Rs m-29,693-15,998 185.6%  
Net Cashflow Rs m-11,674-1,323 882.3%  

Share Holding

Indian Promoters % 48.8 13.5 361.5%  
Foreign collaborators % 3.1 20.1 15.3%  
Indian inst/Mut Fund % 38.0 49.4 76.9%  
FIIs % 21.4 27.7 77.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 66.4 72.6%  
Shareholders   358,459 388,864 92.2%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    SANOFI INDIA    


More on Aurobindo Pharma vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs Cipla Share Price Performance

Period Aurobindo Pharma Cipla S&P BSE HEALTHCARE
1-Day -0.43% 0.19% -0.89%
1-Month -15.24% -1.95% -1.85%
1-Year -34.62% 23.30% -6.83%
3-Year CAGR 0.81% 35.22% 20.56%
5-Year CAGR -7.35% 12.90% 10.73%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of Cipla the stake stands at 33.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 9.0 per share. This amounted to a Dividend Payout ratio of 19.7%.

Cipla paid Rs 5.0, and its dividend payout ratio stood at 15.8%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

NTPC to Build Nuclear Fleet | Inox Group's Big Fundraise to Pare Debt | Top Buzzing Stocks Today(Pre-Open)

On Thursday, Indian share markets extended gains during the last hour of trade to end higher.